RADLY Financials: Raia Drogasil S.A. AI Analysis



Financials

RADLY Financial

Raia Drogasil S.A.

$3.61

4.78%

$0.16

At close: Jul 01, 16:00:00 GMT-4

$3.61

Post-market: Jul 01, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$3.44

Open

$3.37

Day's Range

$3.25 - $3.61

52 week range

$2.3 - $5.34

Volume

298

Avg.Volume

92.5K

Dividend yield

EPS (TTM)

0.15

Market Cap

$6.3B

What is Raia Drogasil SA?

Raia Drogasil SA engages in the retail sale of medicine, perfumery, personal care and beauty products, cosmetics and dermocosmetics. The company is headquartered in Sao Paulo, Sao Paulo and currently employs 73,895 full-time employees. The company went IPO on 2010-10-20. Its main activity is the retail sale of pharmaceutical and cosmetic products, including branded medications, generic medications, OTC (over-the-counter) medications, non-medications (such as personal hygiene products, cosmetics, and dermocosmetics), and various services. The firm has a presence in all federal units of the country, demonstrating its coverage and accessibility. Additionally, the digitalization of the customer journey has been a crucial factor in the Company's growth, enabling a more convenient and efficient shopping experience. The expansion of physical pharmacies, combined with digital solutions, has significantly contributed to Raia Drogasil's continued growth in the Brazilian market.

Features

Markets

News

Breakdown	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025
Revenue	44,768	10,568	12,103	11,264	10,831	10,051
Revenue Growth (YoY)	12%	5%	20%	13%	12%	10%
Cost of Revenue	31,292	7,174	8,538	7,949	7,630	7,167
Gross Profit	13,475	3,394	3,564	3,315	3,200	2,883
Selling, General & Admin	9,101	2,745	2,294	2,073	1,987	1,927
Research & Development	--	--	--	--	--	--
Operating Expenses	10,568	2,750	2,848	2,484	2,485	2,462
Other Non Operating Income (Expenses)	-205	-28	-82	-46	-48	-62
Pretax Income	1,374	126	303	544	399	200
Income Tax Expense	92	-20	12	82	16	35
Net Income	1,291	158	304	453	374	163
Net Income Growth	10%	-3%	-13%	35%	15%	-13%
Shares Outstanding (Diluted)	1,693.02	1,693.02	1,658.5	1,704.14	1,689.91	1,687.39
Shares Change (YoY)	0%	0%	-2%	1%	3%	-4%
EPS (Diluted)	0.75	0.08	0.18	0.26	0.22	0.09
EPS Growth	6%	-12%	-13%	32%	9%	-10%
Free Cash Flow	1,286	509	-12	617	172	250
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	30.09%	32.11%	29.44%	29.43%	29.54%	28.68%
Operating Margin	6.49%	6.09%	5.91%	7.37%	6.6%	4.17%
Profit Margin	2.88%	1.49%	2.51%	4.02%	3.45%	1.62%
Free Cash Flow Margin	2.87%	4.81%	-0.09%	5.47%	1.58%	2.48%
EBITDA	5,047	1,206	1,239	1,339	1,208	901
EBITDA Margin	11.27%	11.41%	10.23%	11.88%	11.15%	8.96%
D&A For EBITDA	2,140	562	523	508	493	481
EBIT	2,907	644	716	831	715	420
EBIT Margin	6.49%	6.09%	5.91%	7.37%	6.6%	4.17%
Effective Tax Rate	6.69%	-15.87%	3.96%	15.07%	4.01%	17.5%

Breakdown

TTM

03/31/2026

12/31/2025

09/30/2025

06/30/2025

03/31/2025

Revenue

44,768

10,568

12,103

11,264

10,831

10,051

Revenue Growth (YoY)

12%

20%

13%

12%

10%

Cost of Revenue

31,292

7,174

8,538

7,949

7,630

7,167

Gross Profit

13,475

3,394

3,564

3,315

3,200

2,883

Selling, General & Admin

9,101

2,745

2,294

2,073

1,987

1,927

Research & Development

Operating Expenses

10,568

2,750

2,848

2,484

2,485

2,462

Other Non Operating Income (Expenses)

-205

-28

-82

-46

-48

-62

Pretax Income

1,374

126

303

544

399

200

Income Tax Expense

-20

Net Income

1,291

158

304

453

374

163

Net Income Growth

10%

-3%

-13%

35%

15%

-13%

Shares Outstanding (Diluted)

1,693.02

1,658.5

1,704.14

1,689.91

1,687.39

Shares Change (YoY)

-2%

-4%

EPS (Diluted)

0.75

0.08

0.18

0.26

0.22

0.09

EPS Growth

-12%

-13%

32%

-10%

Free Cash Flow

1,286

509

-12

617

172

250

Free Cash Flow Per Share

Gross Margin

30.09%

32.11%

29.44%

29.43%

29.54%

28.68%

Operating Margin

6.49%

6.09%

5.91%

7.37%

6.6%

4.17%

Profit Margin

2.88%

1.49%

2.51%

4.02%

3.45%

1.62%

Free Cash Flow Margin

2.87%

4.81%

-0.09%

5.47%

1.58%

2.48%

EBITDA

5,047

1,206

1,239

1,339

1,208

901

EBITDA Margin

11.27%

11.41%

10.23%

11.88%

11.15%

8.96%

D&A For EBITDA

2,140

562

523

508

493

481

EBIT

2,907

644

716

831

715

420

EBIT Margin

6.49%

6.09%

5.91%

7.37%

6.6%

4.17%

Effective Tax Rate

6.69%

-15.87%

3.96%

15.07%

4.01%

17.5%

Follow-Up Questions

What are Raia Drogasil S.A.'s key financial statements?



According to the latest financial statement (Form-10K), Raia Drogasil S.A. has a total asset of $0, Net loss of $0

What are the key financial ratios for RADLY?



Raia Drogasil S.A.'s Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Raia Drogasil S.A.'s revenue broken down by segment or geography?



Raia Drogasil S.A. largest revenue segment is Medicines, Perfumeries, Toiletries and Beauty Products, Cosmetics and Dermocosmetics and Specialty Medicines, at a revenue of 41,547,697,000 in the most earnings release.For geography, Brazil is the primary market for Raia Drogasil S.A., at a revenue of 38,871,522,000.

Is Raia Drogasil S.A. profitable?



no, according to the latest financial statements, Raia Drogasil S.A. has a net loss of $0

Does Raia Drogasil S.A. have any liabilities?



no, Raia Drogasil S.A. has liability of 0

How many outstanding shares for Raia Drogasil S.A.?



Raia Drogasil S.A. has a total outstanding shares of 0

Raia Drogasil S.A. (RADLY) Financial

RADLY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Raia Drogasil SA?

Raia Drogasil S.A. (RADLY) Financial

RADLY Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Raia Drogasil SA?

RADLY Income

Follow-Up Questions

What are Raia Drogasil S.A.'s key financial statements?

What are the key financial ratios for RADLY?

How is Raia Drogasil S.A.'s revenue broken down by segment or geography?

Is Raia Drogasil S.A. profitable?

Does Raia Drogasil S.A. have any liabilities?

How many outstanding shares for Raia Drogasil S.A.?